Insomnia symptoms are associated with return to use and non-fatal overdose following opioid use disorder treatment
These findings underscore the significant role of insomnia in return to opioid use following OUD treatment, highlighting the importance of addressing sleep disturbances early in OUD treatment. This study also suggests that maintaining sleep health during and after treatment could improve the long-term prognosis for OUD. Interventions targeting insomnia are a promising avenue to improve OUD treatment outcomes.
Authors
- Justin C. Strickland (ORCID: https://orcid.org/0000-0003-1077-0394)
- Martin Hochheimer (ORCID: https://orcid.org/0000-0001-6644-4841)
- Andrew S. Huhn (ORCID: https://orcid.org/0000-0002-8073-7701)
- Jill A. Rabinowitz (ORCID: https://orcid.org/0000-0002-3674-8032)
- Jennifer D. Ellis (ORCID: https://orcid.org/0000-0002-8156-6772)
- J. Gregory Hobelmann (ORCID: https://orcid.org/0000-0002-5968-7279)
Institutions
- Rutgers, The State University of New Jersey (US)
- Johns Hopkins University (US)
- Grace (United States) (US)
- Johns Hopkins Medicine (US)
- Johnson University (US)
Publication Details
- Journal
- SLEEP
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1093/sleep/zsae284
- Citations
- 9
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.57